Broadfin Capital’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $2.11M | Sell |
89,730
-8,507
| -9% | -$200K | 0.28% | 33 |
|
2019
Q3 | $1.82M | Sell |
98,237
-559,761
| -85% | -$10.4M | 0.34% | 35 |
|
2019
Q2 | $12.2M | Buy |
657,998
+450,000
| +216% | +$8.37M | 2.66% | 12 |
|
2019
Q1 | $5.08M | Buy |
207,998
+88,704
| +74% | +$2.17M | 1.05% | 30 |
|
2018
Q4 | $3.09M | Sell |
119,294
-171,919
| -59% | -$4.46M | 0.41% | 38 |
|
2018
Q3 | $9.22M | Sell |
291,213
-228,574
| -44% | -$7.23M | 1.36% | 22 |
|
2018
Q2 | $20.2M | Sell |
519,787
-1,061,629
| -67% | -$41.2M | 3.18% | 11 |
|
2018
Q1 | $43.6M | Sell |
1,581,416
-447,102
| -22% | -$12.3M | 6.8% | 3 |
|
2017
Q4 | $36.7M | Sell |
2,028,518
-1,427,192
| -41% | -$25.8M | 6% | 3 |
|
2017
Q3 | $55.8M | Sell |
3,455,710
-962,649
| -22% | -$15.5M | 8.26% | 1 |
|
2017
Q2 | $61.2M | Sell |
4,418,359
-529,044
| -11% | -$7.33M | 7.43% | 1 |
|
2017
Q1 | $74.2M | Buy |
4,947,403
+1,047,816
| +27% | +$15.7M | 8.99% | 2 |
|
2016
Q4 | $51.1M | Buy |
3,899,587
+1,049,587
| +37% | +$13.7M | 5.67% | 4 |
|
2016
Q3 | $49.1M | Buy |
2,850,000
+1,599,896
| +128% | +$27.6M | 4.4% | 7 |
|
2016
Q2 | $22.6M | Sell |
1,250,104
-215,371
| -15% | -$3.89M | 2.19% | 10 |
|
2016
Q1 | $27.8M | Sell |
1,465,475
-766,526
| -34% | -$14.6M | 2.69% | 9 |
|
2015
Q4 | $59.6M | Buy |
2,232,001
+370,000
| +20% | +$9.88M | 3.67% | 4 |
|
2015
Q3 | $45.4M | Sell |
1,862,001
-534,680
| -22% | -$13M | 2.53% | 7 |
|
2015
Q2 | $74.7M | Sell |
2,396,681
-411,492
| -15% | -$12.8M | 4.01% | 3 |
|
2015
Q1 | $40.9M | Hold |
2,808,173
| – | – | 3.18% | 8 |
|
2014
Q4 | $28.3M | Hold |
2,808,173
| – | – | 2.46% | 11 |
|
2014
Q3 | $23.4M | Hold |
2,808,173
| – | – | 2.45% | 11 |
|
2014
Q2 | $34.6M | Buy |
2,808,173
+575,000
| +26% | +$7.08M | 3.37% | 7 |
|
2014
Q1 | $31.1M | Buy |
+2,233,173
| New | +$31.1M | 3.01% | 7 |
|